Full-Time

Data Engineering Manager

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Expert

Hyderabad, Telangana, India

Category
Data Engineering Management
Engineering Management
Data & Analytics
Required Skills
Microsoft Azure
Python
SQL
AWS
Google Cloud Platform
Requirements
  • Experience managing a team of data engineers in biotech/pharma domain companies.
  • Experience in designing and maintaining data pipelines and analytics solutions that extract, transform, and load data from multiple source systems.
  • Demonstrated hands-on experience with cloud platforms (AWS) and the ability to architect cost-effective and scalable data solutions.
  • Experience managing data workflows in cloud environments such as AWS, Azure, or GCP.
  • Strong problem-solving skills with the ability to analyze complex data flow issues and implement sustainable solutions.
  • Working knowledge of SQL, Python, or scripting languages for process monitoring and automation.
  • Experience collaborating with data engineering, analytics, IT operations, and business teams in a matrixed organization.
  • Familiarity with data governance, metadata management, access control, and regulatory requirements (e.g., GDPR, HIPAA, SOX).
  • Excellent leadership, communication, and stakeholder engagement skills.
  • Well versed with full stack development & DataOps automation, logging frameworks, and pipeline orchestration tools.
  • Strong analytical and problem-solving skills to address complex data challenges.
  • Effective communication and interpersonal skills to collaborate with cross-functional teams.
Responsibilities
  • Lead and manage the enterprise data operations team, responsible for data ingestion, processing, validation, quality control, and publishing to various downstream systems.
  • Define and implement standard operating procedures for data lifecycle management, ensuring accuracy, completeness, and integrity of critical data assets.
  • Oversee and continuously improve daily operational workflows, including scheduling, monitoring, and troubleshooting data jobs across cloud and on-premise environments.
  • Establish and track key data operations metrics (SLAs, throughput, latency, data quality, incident resolution) and drive continuous improvements.
  • Partner with data engineering and platform teams to optimize pipelines, support new data integrations, and ensure scalability and resilience of operational data flows.
  • Collaborate with data governance, compliance, and security teams to maintain regulatory compliance, data privacy, and access controls.
  • Serve as the primary escalation point for data incidents and outages, ensuring rapid response and root cause analysis.
  • Build strong relationships with business and analytics teams to understand data consumption patterns, prioritize operational needs, and align with business objectives.
  • Drive adoption of best practices for documentation, metadata, lineage, and change management across data operations processes.
  • Mentor and develop a high-performing team of data operations analysts and leads.
Desired Qualifications
  • Data Engineering Management experience in Biotech/Life Sciences/Pharma
  • Experience using graph databases such as Stardog or Marklogic or Neo4J or Allegrograph, etc.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care by providing effective treatments for serious health conditions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.